Genetic polymorphisms ofMPO,GSTT1,GSTM1,GSTP1,EPHX1andNQO1as risk factors of early‐onset lung cancer

Authors:
  • TLThe LUCY‐Consortium
    The LUCY‐Consortium

Abstract
Early‐onset lung cancer diagnosed up to the age of 50 is a very rare disease, with an increasing incidence rate. Differences in aetiology, characteristics and epidemiology of early and older onset lung cancer have been described previously, suggesting the importance of genetic factors in early‐onset lung cancer aetiology. A case‐control study was conducted to investigate the effects of genetic polymorphisms in theMPO,EPHX1,GSTT1,GSTM1,GSTP1andNQO1genes on the risk of early‐onset lung cancer development. Six hundred thirty‐eight Caucasian patients under the age of 51 with confirmed primary lung cancer and 1,300 cancer free control individuals, matched by age and sex, were included in this analysis. Seventeen single nucleotide polymorphisms and two deletion polymorphisms were genotyped. No significant association was found for any of the analyzed polymorphisms and overall lung cancer risk. Nonsignificantly decreased risk of lung cancer was observed for carriers of 1 or 2 copies ofGSTM1. Subgroup analysis revealed gender‐ and/or smoking‐specific effects ofEPHX1rs2854455 (IV‐1464C > T) and rs2234922 (His139Arg),GSTT1deletion,GSTP1rs1695 (Ile105Val), rs947895 (+991C > A) and rs4891 (Ser185Ser) andNQO1rs1800566 (Pro187Ser) polymorphisms. However, none of the observed effects were confirmed by interaction tests nor were they significant after Bonferroni correction for multiple testing. In summary, our study suggested a modifying effect of polymorphisms inEPHX1,GSTP1,GSTT1,GSTM1andNQO1genes on the risk of early‐onset lung cancer. To confirm these observations and to eliminate possible bias in our analyses, larger studies are warranted.

This publication has 37 references indexed in Scilit: